Osteologie 2011; 20(03): 248-251
DOI: 10.1055/s-0037-1620001
Original and review articles
Schattauer GmbH

Association between reproductive factors and postmenopausal osteoporosis

Zusammenhang zwischen reproduktiven Faktoren und postmenopausaler Osteoporose
H. R. Aghaei Meybodi
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
N. Khalili
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
P. Khashayar
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
R. Heshmat
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
A. Hossein-nezhad
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
B. Larijani
1   Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
› Author Affiliations
Further Information

Publication History

received: 20 February 2011

07 June 2011

Publication Date:
30 December 2017 (online)

Summary

Objective

The present cross-sectional research was designed to study possible correlations between clinical reproductive factors and bone mineral density (BMD) values.

Methods

Using the data gathered by the population-based Iranian Multicenter Osteoporosis Study (IMOS), we investigated the correlation found between reproductive factors and osteoporosis. Subjects were recruited from five major cities of Iran. Bone mineral density was measured using Dual-Energy X-ray Absorptiometry and the results were analyzed against the age at menarche and at menopause, number of pregnancies, children and abortions, and the history (and duration) of breastfeeding.

Results

Data was available for 2528 women. Gravidity and number of children were reversely correlated with BMD. Younger age at menarche was associated with higher BMD values, whereas there was no significant correlation between age at menopause and menstrual history and BMD.

Conclusion

Our study suggests that clinical reproductive factors, particularly number of children and breastfeeding, could be incorporated as predictors of BMD levels in women. Given the controversial results obtained in different studies, longitudinal studies should be carried out to enlighten the importance of these factors and the rationale of their use to predict BMD values in different settings.

Zusammenfassung

Ziel

Die vorliegende Querschnittstudie will mögliche Korrelationen zwischen klinischen reproduktiven Faktoren und der Knochen - mineraldichte (BMD) untersuchen.

Methoden

Anhand von Daten, die bei der populationsbasierten Iranian Multicenter Osteoporosis Study (IMOS) erhoben wurden, untersuchten wir die Korrelation zwischen reproduktiven Faktoren und Osteoporose. Die Teilnehmer der Studie wurden aus fünf iranischen Großstädten rekrutiert. Die mittels DXA ermittelte Knochenmineraldichte (BMD) wurde ausgewertet gegenüber dem Me narchenalter und dem Menopausenalter, der Anzahl an Schwangerschaften, Kindern und Fehlgeburten sowie dem Verlauf (und der Dauer) der Stillzeit.

Ergebnisse

Daten von 2528 Frauen waren verfügbar. Schwangerschaft und Zahl der Kinder korrelierten negativ mit der BMD. Ein geringeres Menarchenalter war mit höheren BMD-Werten verbunden, wohin gegen es keine signifikante Korrelation zwischen Menopausenalter sowie Menstruationsverlauf und der BMD gab.

Schlussfolgerung

Unsere Studie legt nahe, dass klinische Reproduktionsfaktoren, vor allem die Zahl der Kinder und Stillen, als Prädiktoren für die Knochendichte bei Frauen aufgenommen werden könnten. Angesichts der kontroversen Ergebnisse verschiedener Studien sollten Längsschnittstudien durchgeführt werden, um die Bedeutung dieser Faktoren sowie die Begründung ihres Einsatzes in unterschiedlichen Konstellationen für die Vorhersage von BMD-Werten abzuklären.

 
  • References

  • 1 Consensus conference: Osteoporosis. JAMA 1984; 252 (06) 799-802.
  • 2 Maalouf G, Gannagé-Yared MH, Ezzedine J. et al. Middle East and North Africa consensus on osteo-porosis. J Musculoskelet Neuronal Interact 2007; 07 (02) 131-143.
  • 3 Kanis JA, Johnell O, Oden A. et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19 (04) 385-397.
  • 4 World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series. 1994: 843 Geneva: WHO.;
  • 5 Keramat A, Patwardhan B, Larijani B. et al. The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord 2008; 09: 28.
  • 6 Hashemipour S, Larijani B, Adibi H. et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004; 04: 38.
  • 7 Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles’, or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989; 149 (11) 2445-2448.
  • 8 Johnell O, O’Neill T, Felsenberg D. et al. Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol 1997; 146 (04) 287-293.
  • 9 Moayyeri A, Soltani A, Bahrami H. et al. Preferred skeletal site for osteoporosis screening in high-risk populations. Public Health 2006; 120 (09) 863-871.
  • 10 Moayery A, Soltani A, Adibi H. et al. Correlation between sexuality and bone mineral density in Iranian women. Payesh 2003; 01 (03) 49-55.
  • 11 Steib-Furno S, Luc M, Pham T. et al. Pregnancy-related hip diseases: incidence and diagnoses. Joint Bone Spine 2007; 74 (04) 373-378.
  • 12 Allali F, Maaroufi H, Aichaoui SE. et al. Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturitas 2007; 57 (04) 392-398.
  • 13 Meema S, Meema HE. Menopausal bone loss and estrogen replacement. Isr J Med Sci 1976; 12 (07) 601-606.
  • 14 Lindsay R, Hart DM, Aitken JM. et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; 01 (7968): 1038-1041.
  • 15 Aghaei HRMeybodi, Heshmat R. Iranian osteoporosis research network: Back ground, misson and its role in osteoporosis management. Iranian J Public Health 2008; 01: 1-7.
  • 16 Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 1996; 11 (08) 1052-1060.
  • 17 Cure-Cure C, Cure-Ramirez P, Teran E, Lopez-Jaramillo P. Bone-mass peak in multiparity and reduced risk of bone-fractures in menopause. Int J Gynaecol Obstet 2002; 76 (03) 285-291.
  • 18 Cure CC, Ramirez PC, Lopez-Jaramillo P. Osteoporosis, pregnancy, and lactation. Lancet 1998; 352 (9135): 1227-1228.
  • 19 Karlsson C, Obrant KJ, Karlsson M. Pregnancy and lactation confer reversible bone loss in humans. Osteoporos Int 2001; 12 (10) 828-834.
  • 20 Streeten EA, Ryan KA, McBride DJ. et al. The relationship between parity and bone mineral density in women characterized by a homogeneous lifestyle and high parity. J Clin Endocrinol Metab 2005; 90 (08) 4536-4541.
  • 21 Matsushita H, Kurabayashi T, Tomita M. et al. The effect of multiple pregnancies on lumbar bone mineral density in Japanes women. Calcif tissue Int 2002; 71: 10-13.
  • 22 Nguyen TV, Jones G, Sambrook PN. et al. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 1995; 80 (09) 2709-2714.
  • 23 Ribot C, Pouilles JM, Bonneu M, Tremollieres F. Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf) 1992; 36 (03) 225-228.
  • 24 LaFleur J, Dam-Marx C, Kirkness C, Brixner DI. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Ann Pharmacother 2008; 42 (03) 375-386.